Ticagrelor vs. Clopidogrel in Older Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From a Real-World Registry

BACKGROUND AND OBJECTIVES: It is unclear whether more potent P2Y12 inhibitors are of benefit to older patients who are at high risk for both ischemia and bleeding. We conducted an observational study to compare the clinical outcomes of clopidogrel and ticagrelor uses in older patients with an acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yunnan, Peng, Wenxing, Shi, Xiujin, Han, Jialun, Wang, Yifan, Fang, Zhenwei, Lin, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964993/
https://www.ncbi.nlm.nih.gov/pubmed/35369358
http://dx.doi.org/10.3389/fcvm.2022.859962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964993/
https://www.ncbi.nlm.nih.gov/pubmed/35369358
http://dx.doi.org/10.3389/fcvm.2022.859962

Ejemplares similares